Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Spero Oncology

2014 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Operator of a clinical research organization (CRO) focused on development of oncology products. The company provides clinical operations support for oncology clinical trials primarily throughout Europe, but also in Australia and New Zealand.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Decision/Risk Analysis
Other Industries
Pharmaceuticals
Laboratory Services (Healthcare)
Acquirer
Veristat
Primary Office
  • Duart House 3 Finch Way
  • Strathclyde Business Park
  • Bellshill ML4 3PR
  • Scotland

Spero Oncology Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Spero Oncology‘s full profile, request access.

Request full access to PitchBook

Spero Oncology Executive Team (3)

Name Title Board
Seat
Contact
Info
Kathryn Clayton Director, Clinical Operations
Grace Flynn Director, Contracts & Proposals
Theresa Bruce Founder & Managing Director